Nanoimmunotherapy targeting CD40–TRAF6 signalling to reduce atherosclerosis
Crossref DOI link: https://doi.org/10.1038/s41569-018-0024-x
Published Online: 2018-05-01
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lim, Gregory B.
Text and Data Mining valid from 2018-05-01
Article History
First Online: 1 May 2018